The Killam Prize recognizes the career achievements of eminent Canadian scientists actively engaged in research.
See news items about
Glaucoma is one of the most common eye diseases, but most patients won’t know they have it until it’s too late.
Fairchild Radio’s partnership with UHN improves patient education for the Asian community through its annual radiothon coming up March 2nd at Toronto Western Hospital.
Dr. Michael Wheeler, Senior Scientist at Toronto General Research Institute, and U.S. colleagues have identified compounds in the blood that predict diabetes risk better than conventional tests.
Krembil Research Institute Director Dr. Donald Weaver is pursuing a drug for Alzheimer’s disease on many different fronts in his lab.
A new company has been created to advance commercialization of regenerative medicine therapies developed by UHN and the McEwen Centre for Regenerative Medicine.
Did you miss the latest Peter Munk Cardiac Centre Magazine in the November 8, 2016 issue of the Globe and Mail? You can still read it online.
Dr. Ian McGilvray, a Cancer Surgeon and Senior Scientist at University Health Network, is researching how nanoparticles can support the body’s immune system kill liver cancer cells.